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The APHEA 2 project investigated short-term health effects of par-
ticles in eight European cities. In each city associations between par-
 









black smoke and daily counts of emergency hospital admissions
for asthma (0–14 and 15–64 yr), chronic obstructive pulmonary











 effect estimates (percentage change in mean num-








 increase) were asthma (0–14
yr) 1.2% (95% CI: 0.2, 2.3), asthma (15–64 yr) 1.1% (0.3, 1.8), and




 yr) 1.0% (0.4, 1.5) and
0.9% (0.6, 1.3). The combined estimates for Black Smoke tended









 effect estimates between cities was also








 estimates were positively as-
sociated with annual mean concentrations of ozone in the cities. For
asthma admissions (0–14 yr) a number of city-specific factors, in-
cluding smoking prevalence, explained some of their variability.
This study confirms that particle concentrations in European cities
are positively associated with increased numbers of admissions for





estimates between cities can be explained by city characteristics.
Keywords: 
 
particles; respiratory admissions; heterogeneity; APHEA 2
 
The APHEA (Air Pollution and Health: a European Approach)
project was initiated in 1993 with the aim of investigating
whether there was epidemiological evidence for an adverse
short-term effect of air pollution on health (1–2). In the six cit-
ies studied there were small, significant effects of particles and
gases on daily hospital admissions and emergency room visits
for respiratory disease (3–5). This large and comprehensive
study together with evidence from other epidemiological stud-
ies provided substantial evidence that historically low levels of
air pollution were associated with adverse health effects (6–8).
However, there is still debate about the causal nature and im-
portance of these small effects (9, 10). There remain unan-
swered questions concerning the biological mechanisms in-
volved, the identification of the causal pollutant(s), and, not
least, the interpretation and public health significance of the
results (11).
One approach to addressing some of these questions is to
standardize the analytical method and apply it to locations that
differ in environmental and meteorological conditions as well
as in the health status of their populations. In this way, the
consistency of the pollution effect estimates across locations
can be examined, and reasons for any substantial variability or
heterogeneity in the size of the effect estimates can be investi-
gated. The APHEA 2 project was initiated in 1998 with one of
its aims being to tackle these issues. New, more recent datasets









) measurements were available. This paper pre-





 and Black Smoke (BS) and daily numbers of emergency
admissions to hospital for respiratory disease, chronic obstruc-
tive pulmonary disease (COPD), and asthma in eight Euro-
pean cities. A second-stage investigation into possible causes




 effect estimates is also presented. Other
papers from the APHEA 2 group will report findings for mor-
tality, hospital admissions for cardiovascular causes, other pol-





Eight cities in the APHEA 2 group were able to provide hospital ad-
 
missions data. They were Barcelona, Birmingham, London, Milan, The
Netherlands (considered as a city because of its relatively small size
and dense population), Paris, Rome, and Stockholm. Time series of
 
daily counts of admissions were constructed for four groups of admissions:
asthma (International Classification of Diseases, Revision 9 [ICD9]
 










yr. Where possible, emergency admissions resulting in an overnight
hospital stay were specified to exclude elective admissions and those
resulting only in an emergency room visit. The minimum time period
for each series was 3 yr.














) and carbon monoxide (CO) an 8-h average was used,




) the daily maximum 1-h measure was
used. All monitoring stations providing data were subject to criteria
governing data completeness and location. Other environmental (daily
temperature and humidity measures) and social (school and public
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The statistical analyses of these time series data involved two
steps. First, for each time series, a statistical model was constructed
that included terms to describe the seasonal patterns in the admis-
sions, their dependence on temperature and humidity, their associa-
tion with holiday periods and influenza episodes, and finally air pollu-
tion measures. These models provided estimates of the effect of air
pollution on the mean number of admissions per day. The variability
or heterogeneity between the city-specific particle estimates within
each outcome group was assessed using the chi-square test for hetero-
geneity. A significant result indicated that the variation in the effect
estimates was greater than expected by chance and a summary esti-
mate that accounted for this additional variation was calculated (ran-
dom-effects estimate). Otherwise a simple, weighted average of the
estimates or fixed-effects estimate was calculated. Where there was
significant heterogeneity between estimates, further analyses were car-
ried out to investigate possible reasons for this. In this second stage of
the analyses, regression models were used to investigate associations
between the eight particle effect estimates (for an outcome group)
and variables describing the health and environmental conditions in
each city. In this way factors that may affect the toxicity of the parti-
cles or the vulnerability of the exposed population (effect modifiers)
could be explored. The details of these second-stage regressions and a
fuller description of the time series methods used are available in a
supplementary methods section on the Journal’s web site.
The effects on particle estimates of adding a second pollutant were
also investigated in each city, using a series of two-pollutant models.












 were added, in turn, to








 estimates adjusted for the sec-




The combined population in the eight cities totalled 38 mil-
lion. Table 1 gives descriptive statistics for the respiratory out-
comes studied in each city. The median daily number of respi-




 age group ranged from 11 to 55.
The corresponding figures for asthma admissions in the 0–14
and 15–64 yr age groups were 0 to 18 and 0 to 13, respectively.
Table 1 presents statistics for the whole period for which ad-
 

















) N Minimum Median Maximum




 yr 1096 1 11 36
Asthma, 0–14 yr 1096 0 0 4














1096 17.1 53.3 131.7
1/1/94–31/12/96 Black Smoke 1096 14.1 36.2 116.0




 yr 1096 1 18 58
Asthma, 0–14 yr 1096 0 7 39














1017 6.5 21.5 115
1/1/92–31/12/94 Black Smoke 1096 1.5 11.5 57.1




 yr 1096 13 55 150
Asthma, 0–14 yr 1096 2 18 80














1072 7.8 24.9 80.4
1/1/92–31/12/94 Black Smoke 1096 2.3 11.3 55.9




 yr 2922 0 8 38
Asthma, 0–14 yr 2922 0 0 6









 yr 2922 0 2 16
19/1/90–31/12/97 TSP 2904 18.3 60.5 149.2




 yr 2830 11 51 206
Asthma, 0–14 yr 2830 0 5 24














1369 11.3 33.4 130.8
1/1/89–30/9/95 Black Smoke 2464 1.2 9.1 116.6




 yr 1735 1 23 64
Asthma, 0–14 yr 1735 0 5 23














1735 5.8 20.1 80.9
1/1/92–30/9/96 Black Smoke 1735 4.5 18.6 142.2




 yr 1035 3 19 52
Asthma, 0–14 yr 1035 0 1 11









 yr 1035 0 9 24
1/1/95–18/7/97 TSP 930 19.7 69.2 132.6




 yr 3288 0 10 35
Asthma, 0–14 yr 3288 0 1 9


































 particles with an aerodynamic diameter of less
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missions data were available; the series analyzed, however,
varied according to availability of individual pollutants.
Table 1 also summarizes the distributions of the particle
measures for each city. The duration of the particle series













. Two cities (Milan and





















. Five cities provided measures of BS. Correlation








/TSP and BS measures
ranged from 0.5 to 0.8 and the number of monitoring stations
in each city ranged between 1 and 12 (data not shown).
City-specific variables that may account for heterogeneity
in the particle effect estimates are shown in Table 2. Between













































 were positive in all cities, ranging from 0.15 (Rome) to









. Average daily temperature and humidity
levels also varied substantially between cities.









TSP for each outcome studied. Fixed-effect and, where appro-
priate, random-effect estimates are also given.
 
Asthma Admissions, Age 0–14 yr
 
Particle-effect estimates varied substantially between centers,

































2.1, 0.4) to an increase of 2.8%
(95% CI: 0.8, 4.8). The overall random-effects estimate was
1.2% (95% CI: 0.2, 2.3) indicating a positive association be-



















 4. The fixed-effects esti-
mate for BS was 1.3% (95% CI: 0.3, 2.4).
 
Asthma Admissions, Age 15–64 yr
 
Associations with both particle measures were consistently posi-





timate was similar to that for children, 1.1% (95% CI: 0.3, 1.8).





















admissions for COPD and asthma were positive. There was














 7, and, unsur-
prisingly, the fixed and random-effect estimates were very
similar, 1.0% (95% CI: 0.4, 1.5). Results for BS for this sub-





















 and admissions for respiratory
disease were mostly positive and confidence intervals were
generally smaller than for other subgroups reflecting the
larger number of admissions for respiratory disease. For respi-
ratory admissions the summary random-effects model esti-
mate was 0.9% (95% CI: 0.6, 1.3). The BS associations for the
all-respiratory group were more variable, but overall showed




Summary estimates for two-pollutant models are presented in
Table 4 for each of the four outcome groups. The purpose of
these analyses was to assess the sensitivity of the size, direc-




 effect estimates to the inclu-






















. For example, in children
aged 0–14 yr, the change in daily number of admissions associ-












 levels was reduced























 effect estimates but their magnitudes were largely
unchanged. The inclusion of SO
 
2 in the models only modified
PM10 associations in the 0–14 yr age group and the inclusion of
O3 only affected those associations found in admissions for
COPD and asthma in the 65 age group. For CO only particle
effects in the asthma 0–14 yr group were reduced.
Factors Explaining Variability in the PM10 Effect Estimates
The three groups showing evidence of heterogeneity in PM10
effect estimates (asthma admissions in 0–14 yr, admissions for
COPD plus asthma, and all-respiratory admissions in the 65














Deaths‡  65 yr§
Smoking
Prevalence
(%) AreaSO2 O3 NO2 SO2 O3 NO2 Temperature Humidity
Barcelona NA¶ 59.3 94.4 7.9 16.8 77.0 0.32 0.03 0.48 0.02 0.11 740 48 17 36 156
Birmingham 24.3 44.3 75.8 1.1 10.0 78.3 0.77 0.28 0.68 0.13 0.11 895 49 15 29 900
London 23.6 34.9 95.9 1.5 12.0 70.5 0.72 0.00 0.70 0.20 0.04 851 50 14 34 1600
Milan 29.1 43.3 147.0 5.0 14.0 68.4 0.64 0.25 0.72 0.21 0.17 632 41 21 25 182
Netherlands 8.5 57.7 50.1 0.7 10.4 83.1 0.67 0.01 0.64 0.07 0.08 757 52 13 36 41526
Paris 17.7 36.3 87.2 NA¶ 12.3 75.3 0.63 0.11 0.44 0.17 0.12 640 42 9 30 657
Rome 9.8 26.0 139.7 3.9 16.2 60.3 0.15 0.12 0.32 0.21 0.03 585 47 15 35 1283
Stockholm 3.8 66.6 35.6 0.7 8.0 71.1 0.36 0.40 0.30 0.06 0.13 666 31 17 22 500
Definition of abbreviations: PM10  particles with an aerodynamic diameter of less than 10 m.
* Mean daily level.
† Standardized number of deaths due to all causes.
‡ Standardized number of deaths due to lung cancer.
§ Percentage of population over 65 yr old.
 Area of city covered by health statistics.
¶ NA  not available, pollutant not measured.
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yr age groups) were investigated using the 16 potential explan-
atory factors in Table 2. Table 5 gives standardized, second-
stage regression estimates and their standard errors for those
modifiers that reduced the 2 statistic by at least 40%. These
estimates and standard errors indicate the direction, magni-
tude, and precision of the (linear) associations between the
city-specific PM10 estimates and the city-specific levels of the
explanatory factors. The TSP estimates have been scaled to
make them comparable with the PM10/PM13 estimates prior to
these analyses.
TABLE 3. SINGLE POLLUTANT MODEL RESULTS AND POOLED ESTIMATES FOR PARTICLE MEASURE*





Asthma, 0–14 yr Barcelona PM10 2.7 (4.9, 10.9) BS 10.4 (0.4, 21.4)
Birmingham PM10 2.8 (0.8, 4.8) BS 2.0 (1.9, 6.0)
London PM10 0.6 (0.8, 2.0) BS 1.1 (1.3, 3.6)
Milan TSP 3.0 (1.3, 4.8) NA
Netherlands PM10 0.9 (2.1, 0.4) BS 1.4 (0.4, 3.3)
Paris PM13 0.7 (1.5, 3.0) BS 0.9 (0.8, 2.7)
Rome TSP 1.0 (2.4, 4.6) NA
Stockholm PM10 1.7 (6.0, 10.2) NA
Summary estimate PM10 (RE) 1.2 (0.2, 2.3) BS (FE) 1.3 (0.3, 2.4)
Heterogeneity 2  21.3, df  7 2  3.5, df  4
Asthma, 15–64 yr Barcelona PM10 0.4 (3.5, 4.4) BS 2.1 (3.0, 7.5)
Birmingham PM10 2.5 (0.1, 4.9) BS 2.8 (1.9, 7.7)
London PM10 1.4 (0.1, 3.0) BS 1.8 (0.9, 4.5)
Milan TSP 0.3 (1.6, 2.3) NA
Netherlands PM10 0.4 ( 0.9, 1.8) BS 0.4 (2.2. 1.5)
Paris PM13 1.2 (0.7, 3.2) BS 0.8 (0.7, 2.3)
Rome TSP 1.1 (2.2, 4.4) NA
Stockholm PM10 5.4 (4.0, 15.7) NA
Summary estimate PM10 (FE) 1.1 (0.3, 1.8) BS (FE) 0.7 (0.3, 1.8)
Heterogeneity 2  3.6, df  7 2  2.9, df  4
COPD  asthma, 65 yr Barcelona PM10 2.6 (1.0, 4.3) BS 2.1 (4.3, 0.0)
Birmingham PM10 0.5 (1.4, 2.6) BS 2.2 (1.7, 6.2)
London PM10 0.3 (0.8, 1.5) BS 0.4 (1.6, 2.5)
Milan TSP 0.9 (0.0, 1.7) NA
Netherlands PM10 1.1 (0.5, 1.7) BS 0.7 (0.2, 1.6)
Paris PM13 0.6 (2.5, 1.3) BS 0.2 (1.3, 1.6)
Rome TSP 0.5 (0.8, 1.9) NA
Stockholm PM10 2.7 (1.5, 7.1) NA
Summary estimate PM10 (RE) 1.0 (0.4, 1.5) BS (RE) 0.2 (0.7, 1.1)
Heterogeneity 2  9.2, df  7 2  6.6, df  4
All respiratory, 65 yr Barcelona PM10 2.0 (0.8, 3.1) BS 0.7(2.3, 0.9)
Birmingham PM10 0.9 (0.3, 2.2) BS 2.9 (0.6, 5.4)
London PM10 0.4 (0.3, 1.2) BS 1.1 (2.4, 0.3)
Milan TSP 0.8 (0.3, 1.3) NA
Netherlands PM10 1.2 (0.7, 1.6) BS 0.0 (0.7, 0.7)
Paris PM13 0.1 (1.3, 1.0) BS 0.5 (0.4, 1.4)
Rome TSP 0.5 (0.4, 1.5) NA
Stockholm PM10 1.7 (1.2, 4.7) NA
Summary estimate PM10 (RE) 0.9 (0.6, 1.3) BS (RE) 0.1 (0.7, 0.9)
Heterogeneity 2  9.6, df  7 2  10.3, df  4
Definition of abbreviations: BS  Black Smoke; COPD  chronic obstructive pulmonary disease; df  degrees of freedom; FE  fixed-
effects estimates; NA  not available; PM10, PM13  particles with an aerodynamic diameter of less than 10 and 13 m; RE  random-
effects estimates; TSP  total suspended particles; 2  chi-square test for heterogeneity.
* Table gives the associations as percentage change in mean number of admissions associated with 10 g/m3 increases in particle mea-
sures. Only TSP measures were available in Milan and Rome. TSP estimates for Milan and Rome are scaled (PM10  TSP/0.75) for inclusion
in fixed (FE) and random-effects (RE) estimates. PM13 estimates for Paris are assumed to equate to PM10 measures. No BS measurements
were available from Stockholm, Milan, or Rome.
TABLE 4. SUMMARY PM10 ESTIMATES FROM TWO-POLLUTANT MODELS*
Outcome PM10 Only  NO2  O3 PM10 Only
‡  SO2 PM10 Only
§  CO
Asthma, 0–14 yr 1.2 (0.2, 2.3) 0.1 (0.8, 1.0) 1.3 (0.1, 2.5)† 1.3 (0.2, 2.5) 0.8 (3.7, 5.6)† 1.5 (0.2, 2.7) 0.7 (0.3, 1.7)†
Asthma, 15–64 yr 1.1 (0.3, 1.8) 0.4 (0.5, 1.3) 1.1 (0.1, 2.1)† 1.1 (0.3, 1.9) 1.6 (0.6, 2.6) 1.0 (0.2, 1.9) 0.8 (0.2, 1.4)†
COPD  asthma, 65 yr 1.0 (0.4, 1.5) 0.8 (0.6, 2.1)† 0.4 (1.5, 2.2)† 0.9 (0.5, 1.3) 1.3 (0.7, 1.8) 1.1 (0.7, 1.5) 1.0 (0.4, 1.5)†
All respiratory, 65 yr 0.9 (0.6, 1.3) 0.7 (0.3, 1.7)† 0.8 (0.2, 1.4)† 0.9 (0.6, 1.2) 1.1 (0.7, 1.4) 1.1 (0.8, 1.4) 1.0 (0.7, 1.3)
Definition of abbreviations: COPD  chronic obstructive pulmonary disease; PM10  particles with an aerodynamic diameter of less than 10 m.
* Table gives the percentage change in the mean daily number of admissions associated with 10 g/m3 increases in PM10. The estimates are fixed or random-effect (
†) estimates
for all eight cities derived using a second-stage regression of results from city-specific two-pollutant models.
‡ Summary PM10 estimates derived from single-pollutant models excluding Barcelona (no SO2 data available).
§ Summary PM10 estimates derived from single-pollutant models excluding Paris (no CO data available).
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Mean daily O3 levels were positively associated with the
size of the PM10 effect estimates in both the 65 age groups.
Figure 1 illustrates the results for all-respiratory disease and
mean daily O3 levels. It shows the city-specific PM10 regression
coefficients plotted against O3 levels in each center, together
with the estimated regression equation from the second-stage
analysis. There were no such associations with the daily PM10/O3
correlation coefficients within each center. Mean daily humid-
ity levels, the number of PM10 monitoring stations providing
data, smoking prevalence in each city, the standardized num-
ber of lung cancer deaths, and the proportion of the popula-
tion over the age of 65 were all associated with the magnitude
of the PM10 regression coefficients for asthma, 0–14 yr. A scat-
terplot of these data (not shown) suggested that the relation-
ships between regression estimates and values for mean daily
humidity levels and number of monitoring stations were not
convincing and may have been unduly influenced by outliers.
Within-city correlation coefficients between daily PM10 and
humidity levels were not associated with the size of the parti-
cle estimates.
DISCUSSION
In this study we have found small, positive associations be-
tween daily levels of particles and admissions for respiratory
diseases. Summary estimates for PM10 were typically increases
of 1% in mean daily admissions for 10 g/m3 increases in
PM10. Estimates for BS were generally smaller. There was evi-
dence to suggest that large proportions of the between-city
variability in PM10 effect estimates in the two 65 yr age
groups could be explained by average levels of ozone. We
have also shown that, in some instances, the summary particle
effect estimates were either removed or moderated by the in-
clusion of a second pollutant.
The study was designed to examine short-term effects of
particles on respiratory admissions and, in particular, to exam-
ine sources of variability between effect estimates. A number
of potential problems faced in this type of analysis were taken
into account in the design of the study. First, the analyses of
each city’s data were undertaken centrally using a standard-
ized method. This approach reduced the potential for incon-
sistencies in the results that could have arisen from different
analysts applying different methods. Second, by analyzing a
priori lag intervals for each pollutant, the potential for report-
ing spurious relationships between particles and admissions
was minimized. The agreed criteria for including monitoring
stations, uniform treatment of missing pollutant data, stan-
dardized definitions for the daily measures of each pollutant,
together with agreed definitions for each outcome ensured that
the data were collected and processed in a consistent manner
across cities. This further minimizes extraneous sources of
variability in the particle effects. Three centers were unable to
differentiate between emergency and elective admissions. How-
ever, an analysis of the London admissions data suggested that
the lower respiratory series selected for analysis would contain
relatively small numbers of elective admissions (data not shown).
TABLE 5. REGRESSION ESTIMATES (STANDARD ERRORS) FOR EFFECT MODIFIERS IN A














Humidity, daily mean 0.000141 0.000079 12.2, 6 43 7.4 0.001043 0.000585
Smoking prevalence 0.000176 0.000075 10.5, 6 51 7.3 0.001285 0.000548
Population over 65, % 0.000367 0.000106 9.4, 6 56 3.3 0.001211 0.000350
COPD  asthma, 65 yr
Ozone, daily mean 0.000040 0.000020 5.2, 6 43 22.2 0.000888 0.000444
All-respiratory, 65 yr
Ozone, daily mean 0.000033 0.000014 3.9, 6 59 22.2 0.000733 0.000311
Definition of abbreviations: COPD  chronic obstructive pulmonary disease; df  degrees of freedom; EM  effect modifier; IQR  inter-
quartile range; PM10  particles with an aerodynamic diameter of less than 10 m; 
2  chi-square test.
* Regression estimates are from a second-stage linear regression of PM10 coefficients on the effect modifier. The regression coefficients
indicate the change in the PM10 effect estimate on hospital admissions for unit changes in the effect modifiers. Only factors giving at least
a 40% reduction in the 2 statistic are shown. Standardized regression estimates are calculated by multiplying the effect modifier regres-
sion estimate by the interquartile range of the effect modifier. It enables the impact of each effect modifier on the particle effect estimate
to be compared.
Figure 1. Plot of city-specific PM10 regression estimates
against mean daily ozone levels in each city. Individual
cities’ PM10 effect estimates are plotted against mean
daily ozone in each city. The straight line represents the
estimated second-stage regression equation indicating
the association between the magnitude of the PM10 effect
estimates and mean ozone levels.
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Hospital admissions data were available only from eight cities
within the APHEA 2 group. Although this small number of
cities does not pose a problem for the within-city analyses, it
does limit the power of the study in the second-stage regres-
sion analyses. Furthermore, there were no a priori hypotheses
for these analyses and because of the large number of statisti-
cal tests, the results of this second-stage analyses should be in-
terpreted with some caution. As in all time series studies that
rely upon exposure measurements from a small number of
fixed site monitors, there is the potential for exposure misclas-
sification. This type of error can produce a nondifferential bias
and thus a conservative estimation of the effect. In some cases,
however, this type of error can result in an overestimation of
the effect (12). Exposure measurement error may be less of a
problem for fine particles than for gases due to their more ho-
mogeneous geographical distribution (13).
In this analysis separate models were constructed for each
disease outcome to provide the most appropriate control for
confounding factors for each individual series. This approach
was appropriate because the degree of smoothing required to
model seasonal patterns adequately could differ between cit-
ies. Furthermore, this process was carried out prior to the in-
clusion of the particle measures in the statistical models. In
this way potential bias during the model-building stages was
averted.
PM10 data were unavailable to the original APHEA inves-
tigators, so comparisons with results of the original APHEA
meta-analyses are not possible. However, it is possible to com-
pare results from the two projects for BS (3–5). Also, there are
a number of reviews of published studies that can be used for
comparative purposes. For admissions for respiratory disease
Schwartz summarized a selection of U.S. studies and reported
approximate increases in respiratory admissions of 1.3% for
10 g/m3 increases in PM10 (8). This is comparable with the
random-effects summary estimate of 0.9% from the present
study. The U.S. Environmental Protection Agency (EPA) re-
viewed the evidence for health effects of particles, including
admissions time-series studies, and tabulated results from a
large number of studies (14). The EPA reports that particle ef-
fects ranged from approximately 1% to 5% for 10 g/m3 in-
creases.
For COPD plus asthma admissions in the 65 age group,
the particle (PM10) effect estimate from APHEA 2 was
smaller (1.0% for 10 g/m3 increases in PM10) than those
found in five U.S. cities where increases in mean number of
daily admissions ranged from 1.3 to 3.7% for 10 g/m3 in-
creases in PM10 (15). The EPA review reported estimates of
between 1% and 5% for 10 g/m3 increases in PM10 from their
selection of (mainly U.S.) studies (14). The recent National
Morbidity, Mortality and Air Pollution Study (NMMAPS)
studied associations between hospital admissions for COPD
and particles in 14 U.S. cities. They reported a small, signifi-
cant summary effect of PM10 on COPD admissions in those
aged 65 yr, 1.98% (95% CI: 1.49, 2.47) per 10 g/m3 increase
(16). Overall there is a tendency for estimates from European
cities to be smaller than for U.S. cities. However, for BS and
COPD admissions, the results from the APHEA 1 and 2
projects are not inconsistent, 0.7% (95% CI: 0.2, 1.4) and
0.2% (95% CI: 0.7, 1.1) for 10 g/m3 increases in BS, respec-
tively, given the wide confidence intervals.
For admissions for asthma there are fewer studies with
which to compare results, particularly so from the United States,
where routine data collection on admissions is only for those
aged 65 and over. Schwartz reported a 3.7% increase in admis-
sions for asthma in the 0–64 age group in Seattle associated
with a 10 g/m3 increase in PM10 (17). This compares with an
increase in admissions in the 15–64 age group of 1.1% found in
the present study. For BS, Sunyer and coworkers reported a
summary estimate of 0.6% for four cities in APHEA I (5). This
is comparable with the 0.7% summary estimate from five cit-
ies in APHEA 2 (three of which were included in the APHEA
I analysis) with available BS data. Figures for children’s
asthma from the two APHEA studies were 0.9% and 1.3%.
Studying particle effects in different environments was one
of the key motivations behind the APHEA 2 project. In this
way environmental and social factors that explain variation
between cities in the sizes of the particle estimates could be in-
vestigated. For hospitalizations for respiratory disease in the
65 age group there was significant variability in the sizes of
effect estimates. Mean daily ozone levels between cities ex-
plained a significant proportion of this variability (Table 5 and
Figure 1). Daily correlation coefficients between PM10 and O3,
however, did not explain any of this heterogeneity. Further-
more, in two-pollutant models the PM10 summary regression
estimate was largely unaltered by the inclusion of O3. There-
fore, these results suggest that it is the average levels of O3 in
each city rather than the day-to-day covariation between PM10
and O3 that is important in determining the variation in the
particle associations between cities.
It is known that secondary particle levels peak during sum-
mer months when the formation of secondary particles de-
pends upon reactions involving hydroxy radical (OH), O3, and
H2O2 during the photochemical smog formation process (14,
18–20). This process is the same photochemical process that
produces O3. If secondary particle concentrations were more
potent in producing respiratory effects than primary particles
then average O3 concentrations in each city would explain
some of the variation in the PM10 effect estimates. A possible
alternative explanation is that there is a biological interaction
whereby exposure to O3 increases an individual’s sensitivity to
particles. Such an interaction has been shown for ozone and
aeroallergens (21, 22) and this may hold true for air pollution
particles also. The results for all respiratory admissions were
largely replicated in the other 65 yr group studied—those
admitted with COPD or asthma. However, the two-pollutant
models suggested some confounding with O3.
For admissions for asthma for children aged 0–14 yr, the
PM10 regression estimates were confounded with day-to-day
variations in NO2 and SO2 levels but not O3 levels (Table 5).
None of the average pollutant levels including NO2 explained
variation in the size of the particle effect estimates between
cities. This day-to-day confounding with NO2 suggests that the
particle effects observed in this group may be due to particles
derived from a source that is also correlated with the daily lev-
els of NO2, perhaps traffic-related sources. The mean annual
levels of NO2 were not associated with the city-specific parti-
cle effect sizes in the second-stage regressions, suggesting that
NO2 was not involved in the formation of the particles for
which an association with asthma admissions was observed.
However, this category of admissions has the smallest daily
numbers of admissions (Table 1) and so the least power to de-
tect associations with pollutants. The results should therefore
be interpreted with some caution. Both smoking prevalence
and the standardized number of deaths due to lung cancer in
the cities were negatively associated with the PM10 effect esti-
mates. The meaning of these associations is not clear. It may
be that in cities with high smoking rates an individual’s expo-
sure to outdoor particles is a small proportion of their expo-
sure to particles from all sources, indoor and outdoor. As a re-
sult the (small) effects of outdoor particles are not easily
detected. Conversely, young individuals regularly exposed to
tobacco smoke may be less sensitive to relatively low levels of
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outdoor particle pollution. It is not possible to determine from
this study which, if any, of these explanations are true.
In conclusion, this study has confirmed that particle air pol-
lution was associated with daily admissions for respiratory dis-
ease in a selection of European cities. These associations were
consistent with, though generally lower than, results from
other studies, mainly from North America. Average daily
ozone levels explained a large proportion of the between-city
variability in the size of the particle effect estimates in the
over 65 yr age group. These results suggest that secondary par-
ticles, formed by the same photochemistry that produces O3,
may have been responsible for the observed particle effects in
the over 65 yr age group. In children, the particle effects were
confounded with NO2 on a day-to-day basis, suggesting that
traffic-related particles could have been the relevant compo-
nent of the PM10 particle fraction.
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